38.Issue 10 october 25 - INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES

Volume : 12, Issue : 10, October – 2025

Title:

UPDATES IN THE MANAGEMENT OF STATUS EPILEPTICUS IN THE EMERGENCY DEPARTMENT: A REVIEW OF EVIDENCE-BASED GUIDELINES AND NOVEL AGENTS

‏

Authors :

Dubyyan Sati Alshaibani, Fahad Salem Alfaifi, Faisal Abdullah Alzamil, Ali Mohammed Othman Al Zamil, Omar Jazi bin Falah Almutairi, Bader Daher Alotaibi, Tariq Fayeh Alotaibi, Majed Ayedh Alotaibi, Nawaf Saad Al Otabe, Nasser Abdulmohsen Alwatban

Abstract :

Status epilepticus (SE) is a critical neurological emergency requiring urgent, evidence-based management to mitigate high morbidity and mortality. This systematic review synthesizes current evidence and guidelines on the emergency treatment of SE, focusing on recent pharmacological advances. A comprehensive literature search was conducted per PRISMA guidelines across major databases from 2000-2024. The review included RCTs, systematic reviews, and clinical guidelines, with quality assessed via tools like Cochrane RoB 2 and AGREE II. From 2,189 records, 18 studies were included. Findings robustly confirm benzodiazepines as first-line therapy. The practice-changing ESETT trial established “three-drug equipoise” for second-line treatment, demonstrating equivalent efficacy and safety for levetiracetam, fosphenytoin, and valproate. For refractory SE, ketamine emerges as a key third-line agent, with a 63% seizure cessation rate and a favorable hemodynamic profile. Novel agents like brivaracetam, perampanel, and allopregnanolone offer promise for super-refractory cases. Major guidelines consistently endorse a time-sensitive, staged treatment algorithm. In conclusion, emergency SE management is evolving toward protocol-driven care emphasizing rapid benzodiazepine administration, flexible second-line agent selection, and the early use of ketamine. Future research must prioritize RCTs in super-refractory SE and investigate long-term functional outcomes.
Keywords: Status Epilepticus, Emergency Treatment, Refractory Status Epilepticus, Levetiracetam, Ketamine.

Cite This Article:

Please cite this article in press Dubyyan Sati Alshaibani et al., Updates In The Management Of Status Epilepticus In The Emergency Department: A Review Of Evidence-Based Guidelines And Novel Agents, Indo Am. J. P. Sci, 2025; 12(10).

REFERENCES:

1. Alldredge, B. K., Gelb, A. M., Isaacs, S. M., Corry, M. D., Allen, F., Ulrich, S., … & Lowenstein, D. H. (2001). A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. The New England Journal of Medicine, 345(9), 631–637.
2. Almohaish, S., Tesoro, E. P., & Brophy, G. M. (2024). Status epilepticus: an update on pharmacological management. Seminars in Neurology, 44(3), 324–332.
3. Au, C. C., Branco, R. G., & Tasker, R. C. (2017). Management protocols for status epilepticus in the pediatric emergency room: systematic review article. Jornal de Pediatria, 93(Suppl 1), 84-94.
4. Besha, A., Adamu, Y., Mulugeta, H., Zemedkun, A., & Destaw, B. (2023). Evidence-based guideline on management of status epilepticus in adult intensive care unit in resource-limited settings: a review article. Annals of Medicine and Surgery, 85(6), 2714-2720.
5. Betjemann, J. P., & Lowenstein, D. H. (2015). Status epilepticus in adults. The Lancet Neurology, 14(6), 615–624.
6. Betjemann, J. P., Josephson, S. A., Lowenstein, D. H., & Guterman, E. L. (2019). Emergency medical services protocols for generalized convulsive status epilepticus. JAMA, 321(12), 1216-1217.
7. Cao, Y., Li, H., Chen, M., Wang, P., Shi, F., Zhu, X., … & Chen, L. (2024). Evaluation and systematic review of guidance documents for status epilepticus. Epilepsy & Behavior, 150, 109555.
8. Chen, J. W., & Wasterlain, C. G. (2006). Status epilepticus: pathophysiology and management in adults. The Lancet Neurology, 5(3), 246–256.
9. Gavvala, J. R., & Brophy, G. M. (2024). Newer Antiseizure Medications for the Treatment of Status Epilepticus in the Intensive Care Unit. Seminars in Neurology, 44(1), 92–106.
10. Gettings, J. V., Chafjiri, F. M. A., Patel, A. A., Shorvon, S., Goodkin, H. P., & Loddenkemper, T. (2025). Diagnosis and management of status epilepticus: improving the status quo. The Lancet Neurology, 24(1), 65-76.
11. Haider, H. A. (2025). Initial Management of Acute Seizures and Status Epilepticus. Medical Clinics, 109(2), 497-508.
12. Hesdorffer, D. C., Logroscino, G., Cascino, G., Annegers, J. F., & Hauser, W. A. (1998). Incidence of status epilepticus in Rochester, Minnesota, 1965-1984. Neurology, 50(3), 735–741.
13. Heuser, K., Olsen, K. B., Ulvin, L. B., Gjerstad, L., & Taubøll, E. (2022). Modern treatment of status epilepticus in adults. In Epilepsy (pp. 55-78). Exon Publications.
14. John, R., Grahf, D., Lochner, A., Taylor, R., Krupp, S., & Vohra, T. (2022). Evaluation and treatment of adult status epilepticus in the emergency department. Current Emergency and Hospital Medicine Reports, 10(4), 107-115.
15. Joshi, S., & Kapur, J. (2025). Status epilepticus: Updates on mechanisms and treatments. Epilepsia Open.
16. Kapur, J. (2025). Strategies to innovate emergency care of status epilepticus. Neurotherapeutics, 22(1), e00514.
17. Kapur, J., Elm, J., Chamberlain, J. M., Barsan, W., Cloyd, J., Lowenstein, D., … & Silbergleit, R. (2019). Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus. The New England Journal of Medicine, 381(22), 2103–2113.
18. Krumholz, A., Wiebe, S., Gronseth, G. S., Gloss, D. S., Sanchez, A. M., Kabir, A. A., … & French, J. A. (2015). Evidence-based guideline: management of an unprovoked first seizure in adults: report of the Guideline Development Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology, 84(16), 1705-1713.
19. Lowenstein, D. H., Bleck, T., & Macdonald, R. L. (1999). It’s time to revise the definition of status epilepticus. Epilepsia, 40(1), 120–122.
20. Madhiyazhagan, M. (2021). Time is brain: Review of emergency management of status epilepticus in adults. Current Medical Issues, 19(4), 269-273.
21. Messahel, S., Bracken, L., & Appleton, R. (2022). Optimal management of status epilepticus in children in the emergency setting: a review of recent advances. Open Access Emergency Medicine, 14, 491-506.
22. Naylor, D. E., Liu, H., & Wasterlain, C. G. (2005). Trafficking of GABAA receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus. The Journal of Neuroscience, 25(34), 7724–7733.
23. O’Kula, S. S., & Hill, C. E. (2024). Improving quality of care for Status Epilepticus: putting protocols into practice. Current Neurology and Neuroscience Reports, 24(9), 373-379.
24. Penberthy, L. T., Towne, A., Garnett, L. K., Perlin, J. B., & DeLorenzo, R. J. (2005). Estimating the economic burden of status epilepticus to the health care system. Seizure, 14(1), 46–51.
25. Pinto, L. F., Oliveira, J. P. S. D., & Midon, A. M. (2022). Status epilepticus: review on diagnosis, monitoring and treatment. *Arquivos de neuro-psiquiatria, 80*, 193-203.
26. Poblete, R., & Sung, G. (2017). Status epilepticus and beyond: a clinical review of status epilepticus and an update on current management strategies in super-refractory status epilepticus. Korean Journal of Critical Care Medicine, 32(2), 89-105.
27. Rosati, A., De Masi, S., & Guerrini, R. (2021). Ketamine for Refractory Status Epilepticus: A Systematic Review and Meta-Analysis. Frontiers in Neurology, 12, 653674.
28. Shorvon, S., & Ferlisi, M. (2011). The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol. Brain, 134(Pt 10), 2802–2818.
29. Smith, M. D., Sampson, C. S., Wall, S. P., Diercks, D. B., Anderson, J. D., Byyny, R., … & Vandertulip, K. (2024). Clinical policy: critical issues in the management of adult patients presenting to the emergency department with seizures. Annals of Emergency Medicine, 84(1), e1-e12.
30. Sutter, R., Kaplan, P. W., & Rüegg, S. (2024). Outcome and predictors of outcome in refractory status epilepticus. Current Opinion in Critical Care, 30(2), 112–119.
31. Sutter, R., Marsch, S., Fuhr, P., & Rüegg, S. (2013). Mortality and recovery from refractory status epilepticus in the intensive care unit: a 7-year observational study. Epilepsia, 54(3), 502–511.
32. Trinka, E., Cock, H., Hesdorffer, D., Rossetti, A. O., Scheffer, I. E., Shinnar, S., Shorvon, S., & Lowenstein, D. H. (2015). A definition and classification of status epilepticus–Report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia, 56(10), 1515–1523.
33. Vezzani, A., Fujinami, R. S., White, H. S., Preux, P. M., Blümcke, I., Sander, J. W., & Löscher, W. (2016). Infections, inflammation and epilepsy. Acta Neuropathologica, 131(2), 211–234.
34. Vignatelli, L., Tontini, V., Meletti, S., Camerlingo, M., Mazzoni, S., Giovannini, G., … & Di Vito, L. (2024). Clinical practice guidelines on the management of status epilepticus in adults: A systematic review. Epilepsia, 65(6), 1512-1530.
35. Wasterlain, C. G., & Chen, J. W. (2008). Mechanistic and pharmacologic aspects of status epilepticus and its treatment with new antiepileptic drugs. Epilepsia, 49(Suppl 9), 63–73.
36. Wieruszewski, E. D., Brown, C. S., Leung, J. G., & Wieruszewski, P. M. (2020). Pharmacologic management of status epilepticus. AACN Advanced Critical Care, 31(4), 349-356.